Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Uterine Cervical Neoplasms 4Neoplasms 3Breast Neoplasms 3Papillomavirus Infections 2Lung Neoplasms 2Uterine Cervical Diseases 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Pulmonary Atelectasis 1Postural Orthostatic Tachycardia Syndrome 1Postoperative Complications 1Pneumonia 1Pancreatic carcinoma, familial 1Pancreatic cancer, adult 1Multiple Myeloma 1Mastocytosis 1Lung Cancer Screening 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1HIV Infections 1Financial Stress 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cervical Cancer Screening 1Bronchopulmonary Disease 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

venetoclax 69Cyclophosphamide 53ibrutinib 44obinutuzumab 43acalabrutinib 42Rituximab 40fludarabine 37fludarabine phosphate 30Specimen Handling 29pirtobrutinib 25Biopsy 24zanubrutinib 23Whole-Body Irradiation 16Bendamustine Hydrochloride 15Magnetic Resonance Spectroscopy 14Mycophenolic Acid 13Lenalidomide 11Peripheral Blood Stem Cell Transplantation 9Sirolimus 8idelalisib 7Tacrolimus 7CT-P10 7ARQ531 7tafasitamab 6Prednisone 6Busulfan 6pembrolizumab 5Stem Cell Transplantation 5Melphalan 5Interleukin-2 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Lymphocytic, Chronic, B-Cell × Mass Screening × 1 year × Clear all
NCT05844033 2026-05-19

Biomarker for Infection Risk in CLL and MM

Massachusetts General Hospital

Active not recruiting
150 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡